Growth inhibition of CD20-positive B lymphoma cell lines by IDEC-C2B8 anti-CD20 monoclonal antibody

Japanese Journal of Cancer Research

Volumn 89, Issue 7, 1998, Pages 748-756

  Taji, Hirohumi ^a   Kagami, Yoshitoyo ^a   Okada, Yasutaka ^a   Andou, Manahu ^a   Nishi, Yoshimi ^a   Saito, Hidehiko ^b   Seto, Masao ^a   Morishima, Yasuo ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti CD20 antibody; Apoptosis; B cell lymphoma

Indexed keywords

CHIMERIC ANTIBODY; MONOCLONAL ANTIBODY; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CANCER IMMUNOTHERAPY; CELL MEMBRANE; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; LYMPHOMA CELL LINE; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL;

EID: 0031693706     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb03280.x     Document Type: Article

References (33)

1. Waldmann, T. A. Monoclonal antibodies in diagnosis and therapy. Science, 252, 1657-1662 (1991).
2. Grossbard, M. L., Press O. W., Appelbaum, F. R., Bernstein, I. D. and Nadler, L. M. Monoclonal antibody-based therapies of leukemia and lymphoma. Blood, 80, 863-878 (1992).
3. Meeker, T. C., Lowder, J., Maloney, D. G., Miller, R. A., Thielemans, K., Warnke, R. and Levy, R. A clinical trial of anti-idiotype therapy for B cell malignancy. Blood, 65, 1349-1363 (1985).
4. Kwak, L. W., Campbell, M. J., Czerwinski, D. K., Hart, S., Miller, R. A. and Levy, R. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N. Engl. J. Med., 327, 1209-1215 (1992).
5. Hsu, F. J., Casper, C. B., Czerwinski, D., Kwak, L. W., Liles, T. M., Syrengelas, A., Taidi-Laskowski, B. and Levy, R. Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma - long-term results of a clinical trial. Blood, 89, 3129-3135 (1997).
6. Hale, G., Dyer, M. J. S., Clark, M. R., Phillips, J. M., Marcus, R., Riechmann, L., Winter, G. and Waldmann, H. Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H. Lancet, ii, 1394-1399 (1988).
7. Dyer, M. J. S., Hale, G., Frank, G. J., Hayhoe, F. G. J. and Waldmann, H. Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype. Blood, 73, 1431-1439 (1989).
8. Reff, M. E., Carner, K., Chambers, K. S., Chinn, P. C., Leonard, J. E., Raab, R., Newman, R. A., Hanna, N. and Anderson, D. R. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood, 83, 435-445 (1994).
9. Maloney, D. G., Liles, T. M., Czerwinski, D. K., Waldichuk, C., Rosenberg, J., Grillo-López, A. and Levy, R. Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma. Blood, 84, 2457-2466 (1994).
10. Maloney, D. G., Grillo-López, A. J., Bodkin, D., White, C., Foon, K., Schilder, R. J., Neidhart, J., Janakiraman, N., Waldichuk, C., Davis, T., Dallaire, B. K., Royston, I. and Levy, R. IDEC-C2B8 anti-CD20 antibody: results of long-term follow-up of relapsed NHL Phase II trial patients. Blood, 86, 54a (1995) (abstr.).
11. Czuczman, M. S., Grillo-López, A. J., Jonas, C., Gordon, L., Saleh, M., White, C. A., Varns, C. and Rogers, J. IDEC-C2B8 and CHOP chemoimmunotherapy of lowgrade lymphoma. Blood, 86, 55a (1995) (abstr.).
12. Tedder, T. F. and Engel, P. CD20: a regulator of cell-cycle progression of B lymphocytes. Immunol. Today, 15, 450-454 (1994).
13. Epstein, A. L., Marder, R. J., Winter, J. N. and Fox, R. I. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors. J. Immunol., 133, 1028-1036 (1987).
14. Siminovitch, K. A., Jensen, J. P., Epstein, A. L. and Korsmeyer, S. J. Immunoglobulin genes rearrangements and expression in diffuse histiocytic lymphomas reveal cellular lineage, molecular defects, and sites of chromosomal translocation. Blood, 67, 391-397 (1986).
15. Bakhshi, A., Jensen, J. P., Goldman, P., Wright, J. J., McBride, O. W., Epstein, A. L. and Korsmeyer, S. J. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell, 41, 899-906 (1985).
16. Daibata, M., Takasaki, M., Hirose, S., Kubonishi, I., Taguchi, H., Ohtsuki, Y. and Miyoshi, I. Establishment of a new human B cell line carrying t(11;14) chromosome abnormality. Jpn. J. Cancer Res., 78, 1182-1185 (1987).
17. Akao, Y., Seto, M., Takahashi, T., Saito, M., Utsumi, K. R., Nakazawa, S. and Ueda, R. Rearrangements on chromosome 11q23 in hematopoietic tumor-associated t(11;14) and t(11;19) translocations. Cancer Res., 51, 6708-6711 (1991).
18. Hiraki, S., Miyoshi, I., Kubonishi, I., Matsuda, Y., Nakayama, T., Kishimoto, H. and Masuji, H. Human leukemic "null" cell line (NALL-1). Cancer, 40, 2131-2135 (1977).
19. Sahai Srivastava, B. I. and Minowada, J. Terminal deoxynucleotidyl transferase activity in a cell line (Molt-4) derived from the peripheral blood of a patient with acute lymphoblastic leukemia. Biochem. Biophys. Res. Commun., 51, 529-535 (1973).
20. Bikoue, A., George, F., Poncelet, P., Mutin, M., Janossy, G. and Sampol, J. Quantitative analysis of leukocyte membrane antigen expression: normal adult values. Cytometry, 26, 137-147 (1996).
21. Denny, T. N., Stein, D., Mui, T., Scolpino, A. and Holland, B. Quantitative determination of surface antibody binding capacities of immune subsets present in peripheral blood of healthy adult donors. Cytometry, 26, 265-274 (1996).
22. Koopman, G., Reutelingsperger, C. P. M., Kuijten, G. A. M., Keehnen, R. M. J., Pals, S. T. and van Oers, M. H. J. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood, 84, 1415-1420 (1994).
23. Homburg, C. H. E., de Haas, M., von dem Borne, A. E. G. Kr., Verhoeven, A. J., Reutelingersperger, C. P. M. and Roos, D. Human neutrophils lose their surface Fc γ RIII and acquire annexin V binding sites during apoptosis in vitro. Blood, 85, 532-540 (1995).
24. Darzynkiewicz, Z., Juan, G., Li, X., Gorczyca, W., Murakami, T. and Traganos, F. Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry, 27, 1-20 (1997).
25. Kerr, J. F., Wyllie, A. H. and Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26, 239-257 (1972).
26. Rosenberg, J., Waldchuk, C., Grillo-López, A. J., Leonard, J. E. and Dallaire, B. K. Pharmacokinetic analysis of serum concentrations of the chimeric anti-CD20 antibody IDEC-C2B8 in patients with relapsed B cell lymphoma. Proc. Am. Soc. Clin. Oncol., 15, 418 (1996) (abstr.).
27. Tedder, T. F., Boyd, A. W., Freedman, A. S., Nadler, L. M. and Schlossman, S. F. The B cell surface molecule B1 is functionally linked with B cell activation and differentiation. J Immunol., 135, 973-979 (1985).
28. Tedder, T. F., Forsgren, A., Boyd, A. W., Nadler, L. M. and Schlossman, S. F. Antibodies reactive with B1 molecule inhibit cell cycle progression but not activation of human B lymphocyte. Eur. J. Immunol., 16, 881-887 (1986).
29. Golay, J. T., Clark, E. A. and Beverley, P. C. L. The CD20 (Bp35) antigen involved in activation of B cells from the GO to the G1 phase of the cell cycle. J. Immunol., 135, 3795-3801 (1985).
30. Yonehara, S., Ishii, A. and Yonehara, M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen codownregulated with the receptor of tumor necrosis factor. J. Exp. Med., 169, 1747-1756 (1989).
31. Holder, M., Grafton, G., MacDonald, I., Finney, M. and Gordon, J. Engagement of CD20 suppresses apoptosis in germinal center B cells. Eur. J. Immunol., 25, 3160-3164 (1994).
32. Valentine, M. A. and Licciardi, K. A. Rescue from anti-IgM-induced programmed cell death by the B cell surface proteins CD20 and CD40. Eur. J. Immunol., 22, 3141-3148 (1992).
33. Shan, D., Ledbetter, J. A. and Press, O. W. Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies. Blood, 91, 1644-1652 (1998).